Acquisition Opportunity Bellevue Pharmacy was acquired by Hartig Drug Company in 2020, signaling a potential channel for cross-sell of Hartig’s products and services, including wholesale pharmaceutical solutions, supply chain efficiencies, and additional patient care programs.

Specialty Focus As one of the country’s largest specialty pharmacies with PCAB accreditation and DynaLabs Center of Excellence status, Bellevue presents an opportunity to collaborate on high-complexity compounded therapies, quality manufacturing processes, and adherence programs that appeal to high-value payer contracts.

Scale and Reach With 51-200 employees and revenue in the 25–50 million range, Bellevue operates at a mid-market scale that can benefit from partnerships on backend operations, compliance tooling, and technology integrations to improve efficiency and expand service lines.

High Touch Model The Power of Personal approach and end-to-end patient-centric solutions indicate strong potential for services around patient engagement platforms, physician support tools, and omni-channel communication services to elevate adherence and outcomes.

Technology Footprint Existing tech stack includes modern web and marketing technologies; opportunities exist to partner on digital marketing collaboration, patient portals, and data analytics to optimize patient outreach, segmentation, and program effectiveness.